To provide a mechanistic explanation of the inhibitory activities of Flavipin on breast cancer cells, we examined selected anti-apoptotic (Bcl2), adhesion (ITGA4) and pro-metastatic (Sox4) markers. The gene discussed is SOX4; the disease is breast carcinoma.